Table 2.
Genotype | N Control/N Case | Univariate analysis | Multivariate analysis1 | ||
---|---|---|---|---|---|
|
|
||||
OR (95% CI) | P | OR (95% CI) | P | ||
SNAI1 rs1047920 C>T | |||||
CC | 20787/24943 | 1.00 | 1.00 | ||
CT | 3324/3633 | 0.91 (0.87-0.96) | 0.0003 | 0.91 (0.87-0.96) | 0.0003 |
TT | 124/152 | 1.02 (0.81-1.30) | 0.861 | 1.02 (0.80-1.30) | 0.869 |
Trend test | 0.001 | 0.001 | |||
CT+TT | 3448/3785 | 0.92 (0.87-0.96) | 0.0004 | 0.91 (0.87-0.96) | 0.0004 |
AMDHD1 rs11826 C>T | |||||
CC | 14033/16940 | 1.00 | 1.00 | ||
CT | 8761/10232 | 0.97 (0.93-1.00) | 0.074 | 0.97 (0.93-1.00) | 0.069 |
TT | 1441/1556 | 0.89 (0.83-0.96) | 0.004 | 0.89 (0.82-0.96) | 0.002 |
Trend test | 0.002 | 0.002 | |||
CT+TT | 10202/11788 | 0.96 (0.93-0.99) | 0.013 | 0.96 (0.92-0.99) | 0.011 |
CUBN rs3914238 C>T | |||||
CC | 9676/11076 | 1.00 | 1.00 | ||
CT | 11183/13510 | 1.06 (1.02-1.10) | 0.004 | 1.05 (1.02-1.09) | 0.006 |
TT | 3376/4142 | 1.07 (1.02-1.13) | 0.010 | 1.07 (1.01-1.13) | 0.014 |
Trend test | 0.002 | 0.003 | |||
CT+TT | 14559/17652 | 1.06 (1.02-1.10) | 0.001 | 1.06 (1.02-1.10) | 0.002 |
Number of combined risk genotypes2 | |||||
0 | 596/628 | 1.00 | 1.00 | ||
1 | 5128/5640 | 1.04 (0.93-1.18) | 0.475 | 1.05 (0.93-1.18) | 0.451 |
2 | 11284/13489 | 1.14 (1.01-1.27) | 0.031 | 1.14 (1.01-1.28) | 0.028 |
3 | 7232/8976 | 1.18 (1.05-1.32) | 0.006 | 1.18 (1.05-1.33) | 0.005 |
Trend test | <0.0001 | <0.0001 | |||
0-2 | 17008/19757 | 1.00 | 1.00 | ||
3 | 7232/8976 | 1.07 (1.03-1.11) | 0.0005 | 1.07 (1.03-1.11) | 0.0005 |
Abbreviations: AMDHD1, amidohydrolase domain containing 1; BC: breast cancer; CI: confidence interval; CUBN, cubilin; DRIVE: Discovery, Biology, and Risk of Inherited Variants in Breast Cancer; OR: odds ratio; SNAI1, snail family transcriptional repressor 1; SNP: single nucleotide polymorphism.
Adjusted for age, PC1, PC3, PC4, PC5, PC6, PC8, PC10, PC11, PC14 and PC16.
Risk genotypes were rs1047920 CC, rs11826 CC and rs3914238 CT+TT.